Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Follow-Up Study for Exubera

ClinicalTrials.gov ID: NCT00734591

Public ClinicalTrials.gov record NCT00734591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

In studies of Exubera in persons with diabetes, lung cancer occurred in a few more people who were taking Exubera than in people who were taking other diabetes medicines. All subjects diagnosed with lung cancer had a history of smoking and the number of lung cancer cases observed fell within the expected range based on population-based data. There is currently not enough information to determine if any of the observed lung cancer cases were related to Exubera use, therefore, the study is being conducted to further investigate whether Exubera use makes the appearance of lung cancer more likely.

Study identification

NCT ID
NCT00734591
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Pfizer
Industry
Enrollment
7,439 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2008 (Type not available)
Primary completion
Jan 2012 (Actual)
Completion
Jan 2012 (Actual)
Last update posted
Oct 23, 2012

2008 – 2012

United States locations

U.S. sites
131
U.S. states
36
U.S. cities
114
Facility City State ZIP Site status
Pfizer Investigational Site Bay Minette Alabama 36507 —
Pfizer Investigational Site Graysville Alabama 35073 —
Pfizer Investigational Site Pell City Alabama 35125 —
Pfizer Investigational Site Pell City Alabama 35128 —
Pfizer Investigational Site Glendale Arizona 85306 —
Pfizer Investigational Site Phoenix Arizona 85006 —
Pfizer Investigational Site Phoenix Arizona 85016 —
Pfizer Investigational Site Phoenix Arizona 85028 —
Pfizer Investigational Site Phoenix Arizona 85051 —
Pfizer Investigational Site Forrest City Arkansas 72335 —
Pfizer Investigational Site Berkeley California 94705 —
Pfizer Investigational Site Concord California 94520 —
Pfizer Investigational Site El Cajon California 92019 —
Pfizer Investigational Site Encino California 91436 —
Pfizer Investigational Site Fresno California 93720 —
Pfizer Investigational Site Fullerton California 92835 —
Pfizer Investigational Site Huntington Beach California 92648 —
Pfizer Investigational Site Long Beach California 90806 —
Pfizer Investigational Site Los Angeles California 90073 —
Pfizer Investigational Site Rolling Hills Estates California 90274 —
Pfizer Investigational Site San Diego California 92120 —
Pfizer Investigational Site San Diego California 92128 —
Pfizer Investigational Site San Jose California 95116 —
Pfizer Investigational Site Santa Ana California 92704 —
Pfizer Investigational Site Santa Barbara California 93105 —
Pfizer Investigational Site Tustin California 92780 —
Pfizer Investigational Site Denver Colorado 80206 —
Pfizer Investigational Site Denver Colorado 80209 —
Pfizer Investigational Site Denver Colorado 80220 —
Pfizer Investigational Site Golden Colorado 80401 —
Pfizer Investigational Site Longmont Colorado 80501 —
Pfizer Investigational Site Milford Connecticut 06460 —
Pfizer Investigational Site Newark Delaware 19713 —
Pfizer Investigational Site Washington D.C. District of Columbia 20010 —
Pfizer Investigational Site Washington D.C. District of Columbia 20307 —
Pfizer Investigational Site Boca Raton Florida 33433 —
Pfizer Investigational Site Chiefland Florida 32626 —
Pfizer Investigational Site Green Cove Springs Florida 32043 —
Pfizer Investigational Site Kissimmee Florida 34743 —
Pfizer Investigational Site Lake City Florida 32025 —
Pfizer Investigational Site Lake Mary Florida 32746 —
Pfizer Investigational Site Miami Florida 33136 —
Pfizer Investigational Site Opa-locka Florida 33054-3818 —
Pfizer Investigational Site Saint Cloud Florida 34769 —
Pfizer Investigational Site Tampa Florida 33624 —
Pfizer Investigational Site West Palm Beach Florida 33401 —
Pfizer Investigational Site Atlanta Georgia 30318-2513 —
Pfizer Investigational Site Atlanta Georgia 30342 —
Pfizer Investigational Site Conyers Georgia 30013 —
Pfizer Investigational Site Decatur Georgia 30035 —
Pfizer Investigational Site Honolulu Hawaii 96813 —
Pfizer Investigational Site Honolulu Hawaii 96814 —
Pfizer Investigational Site Hayden Lake Idaho 83835 —
Pfizer Investigational Site Greenville Illinois 62246 —
Pfizer Investigational Site Normal Illinois 61761 —
Pfizer Investigational Site Olympia Fields Illinois 60461 —
Pfizer Investigational Site Springfield Illinois 62704 —
Pfizer Investigational Site Fishers Indiana 46038 —
Pfizer Investigational Site Indianapolis Indiana 46229 —
Pfizer Investigational Site Indianapolis Indiana 46254-5472 —
Pfizer Investigational Site Des Moines Iowa 50314 —
Pfizer Investigational Site Des Moines Iowa 50315 —
Pfizer Investigational Site Dubuque Iowa 52002 —
Pfizer Investigational Site Wichita Kansas 67203 —
Pfizer Investigational Site Louisville Kentucky 40213 —
Pfizer Investigational Site Louisville Kentucky 40258 —
Pfizer Investigational Site Mount Sterling Kentucky 40353 —
Pfizer Investigational Site Baltimore Maryland 21204 —
Pfizer Investigational Site Elkton Maryland 21921 —
Pfizer Investigational Site Glen Burnie Maryland 21061 —
Pfizer Investigational Site Wheaton Maryland 20902 —
Pfizer Investigational Site Boston Massachusetts 02114 —
Pfizer Investigational Site Springfield Massachusetts 01105 —
Pfizer Investigational Site Ann Arbor Michigan 48104 —
Pfizer Investigational Site Clinton Michigan 49236 —
Pfizer Investigational Site Flint Michigan 48532 —
Pfizer Investigational Site Muskegon Michigan 49444 —
Pfizer Investigational Site Saint Cloud Minnesota 56301 —
Pfizer Investigational Site Kansas City Missouri 64116 —
Pfizer Investigational Site Springfield Missouri 65807 —
Pfizer Investigational Site Incline Village Nevada 89452 —
Pfizer Investigational Site Las Vegas Nevada 89128 —
Pfizer Investigational Site Belvidere New Jersey 07823 —
Pfizer Investigational Site New Brunswick New Jersey 08901 —
Pfizer Investigational Site Albuquerque New Mexico 87106 —
Pfizer Investigational Site Albany New York 12208 —
Pfizer Investigational Site Babylon New York 11702 —
Pfizer Investigational Site Brooklyn New York 11224 —
Pfizer Investigational Site Minneola New York 11501 —
Pfizer Investigational Site New Hartford New York 13413 —
Pfizer Investigational Site Syracuse New York 13210 —
Pfizer Investigational Site Williamsville New York 14221 —
Pfizer Investigational Site Asheboro North Carolina 27203 —
Pfizer Investigational Site Charlotte North Carolina 28227 —
Pfizer Investigational Site Durham North Carolina 27713 —
Pfizer Investigational Site Morehead City North Carolina 28557-3126 —
Pfizer Investigational Site Raleigh North Carolina 27609 —
Pfizer Investigational Site Tabor City North Carolina 28463 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Columbus Ohio 43207 —
Pfizer Investigational Site Dayton Ohio 45419 —
Pfizer Investigational Site Kettering Ohio 45429 —
Pfizer Investigational Site Marietta Ohio 45750 —
Pfizer Investigational Site Portland Oregon 97210 —
Pfizer Investigational Site Portland Oregon 97232 —
Pfizer Investigational Site Fogelsville Pennsylvania 18051 —
Pfizer Investigational Site Hanover Pennsylvania 17331 —
Pfizer Investigational Site Harrisburg Pennsylvania 17112 —
Pfizer Investigational Site Jeannette Pennsylvania 15644 —
Pfizer Investigational Site Jersey Shore Pennsylvania 17740 —
Pfizer Investigational Site Lansdale Pennsylvania 19446 —
Pfizer Investigational Site Melrose Park Pennsylvania 19027 —
Pfizer Investigational Site Philadelphia Pennsylvania 19153-2326 —
Pfizer Investigational Site Charleston South Carolina 29412 —
Pfizer Investigational Site North Myrtle Beach South Carolina 29582 —
Pfizer Investigational Site Beaumont Texas 77701 —
Pfizer Investigational Site Dallas Texas 75246 —
Pfizer Investigational Site Houston Texas 77008 —
Pfizer Investigational Site Houston Texas 77079 —
Pfizer Investigational Site Kaufman Texas 75142 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site San Marcos Texas 78666 —
Pfizer Investigational Site Stephenville Texas 76401 —
Pfizer Investigational Site Webster Texas 77598 —
Pfizer Investigational Site South Burlington Vermont 05403 —
Pfizer Investigational Site Richmond Virginia 23225-4017 —
Pfizer Investigational Site Richmond Virginia 23294 —
Pfizer Investigational Site Federal Way Washington 98003 —
Pfizer Investigational Site Spokane Washington 99204 —
Pfizer Investigational Site Spokane Washington 99207 —
Pfizer Investigational Site Burnsville West Virginia 26335 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 190 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00734591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2012 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00734591 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →